Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.
Completed · Phase 3
Conditions studied: Postpartum Hemorrhage
In brief
Although prior dose-finding studies have investigated the optimal bolus dose of oxytocin to initiate adequate uterine tone, it is unclear what oxytocin infusion regimen is required to maintain adequate uterine tone after delivery. The study investigators aim to compare two different infusion rates of oxytocin to assess the optimal infusion regimen for reducing blood loss in women undergoing elective Cesarean delivery.
Key facts
- Study ID
- NCT01932060
- Run by
- Stanford University
- People needed
- 51
- Starts
- 2013-08-01
- Expected to finish
- 2015-09-01
- Last updated by the study team
- 2017-02-01
Who can join
Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Healthy pregnant patients with uncomplicated pregnancies:
- ASA (American Association of Anesthesiologists) class 1 or 2 patients.
- Singleton pregnancies.
You may not qualify if…
- ASA class 3 or 4 patients.
- Known drug allergy to intravenous oxytocin.
- Significant medical or obstetric disease.
- Known uterine abnormality.
- Known placental abnormality.
Where it is running
- Lucile Packard Children's Hospital, Stanford University — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.